These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7754280)

  • 1. Anatomy of the prostate and distribution of early prostate cancer.
    Greene DR; Fitzpatrick JM; Scardino PT
    Semin Surg Oncol; 1995; 11(1):9-22. PubMed ID: 7754280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.
    Greene DR; Taylor SR; Wheeler TM; Scardino PT
    Cancer Res; 1991 Aug; 51(15):4084-9. PubMed ID: 1855223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of the individual prostate cancer focus.
    Greene DR; Wheeler TM
    Cancer Invest; 1994; 12(4):425-37. PubMed ID: 8032966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate.
    Greene DR; Wheeler TM; Egawa S; Dunn JK; Scardino PT
    J Urol; 1991 Oct; 146(4):1069-76. PubMed ID: 1895423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some small prostate cancers are nondiploid by nuclear image analysis: correlation of deoxyribonucleic acid ploidy status and pathological features.
    Greene DR; Rogers E; Wessels EC; Wheeler TM; Taylor SR; Santucci RA; Thompson TC; Scardino PT
    J Urol; 1994 May; 151(5):1301-7. PubMed ID: 8158775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of 148 consecutive transition zone cancers: clinical and histological characteristics.
    Noguchi M; Stamey TA; Neal JE; Yemoto CE
    J Urol; 2000 Jun; 163(6):1751-5. PubMed ID: 10799175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The distribution of residual cancer in radical prostatectomy specimens in stage A prostate cancer.
    Greene DR; Egawa S; Neerhut G; Flanagan W; Wheeler TM; Scardino PT
    J Urol; 1991 Feb; 145(2):324-8; discussion 328-9. PubMed ID: 1988723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer is highly predictable: a prognostic equation based on all morphological variables in radical prostatectomy specimens.
    Stamey TA; Yemoto CM; McNeal JE; Sigal BM; Johnstone IM
    J Urol; 2000 Apr; 163(4):1155-60. PubMed ID: 10737486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
    Noguchi M; Stamey TA; McNeal JE; Yemoto CM
    J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The extent and zonal location of prostatic intraepithelial neoplasia and atypical adenomatous hyperplasia: relationship with carcinoma in radical prostatectomy specimens.
    Qian J; Bostwick DG
    Pathol Res Pract; 1995 Sep; 191(9):860-7. PubMed ID: 8606866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central zone carcinoma of the prostate gland: a distinct tumor type with poor prognostic features.
    Cohen RJ; Shannon BA; Phillips M; Moorin RE; Wheeler TM; Garrett KL
    J Urol; 2008 May; 179(5):1762-7; discussion 1767. PubMed ID: 18343454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between clinical stage and histological zone of origin in early prostate cancer: morphometric analysis.
    Greene DR; Wheeler TM; Egawa S; Weaver RP; Scardino PT
    Br J Urol; 1991 Nov; 68(5):499-509. PubMed ID: 1747726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological parameters of radical prostatectomy for clinical stages T1c versus T2 prostate adenocarcinoma: decreased pathological stage and increased detection of transition zone tumors.
    Jack GS; Cookson MS; Coffey CS; Vader V; Roberts RL; Chang SS; Smith JA; Shappell SB
    J Urol; 2002 Aug; 168(2):519-24. PubMed ID: 12131301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal ablation of prostatic cancer: effects on prostate morphology, tumor detection, and staging by endorectal coil MR imaging.
    Chen M; Hricak H; Kalbhen CL; Kurhanewicz J; Vigneron DB; Weiss JM; Carroll PR
    AJR Am J Roentgenol; 1996 May; 166(5):1157-63. PubMed ID: 8615261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transrectal ultrasonography in stage A prostate cancer: detection of residual tumor after transurethral resection of prostate.
    Egawa S; Greene DR; Flanagan WF; Wheeler TM; Scardino PT
    J Urol; 1991 Aug; 146(2):366-71. PubMed ID: 1856933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macroscopic features of prostate cancer.
    Lindh C; Delahunt B; Egevad L
    Pathology; 2018 Jun; 50(4):382-388. PubMed ID: 29709289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.
    Robertson CN; Paulson DF
    Acta Oncol; 1991; 30(2):205-7. PubMed ID: 2029406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of prostatic carcinoma. Morphometric and pathologic features of early stages.
    Villers AA; McNeal JE; Freiha FS; Stamey TA
    Acta Oncol; 1991; 30(2):145-51. PubMed ID: 1851426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis.
    Quick CM; Gokden N; Sangoi AR; Brooks JD; McKenney JK
    Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of pathologic stage and postprostatectomy disease recurrence by DNA ploidy analysis of initial needle biopsy specimens of prostate cancer.
    Ross JS; Figge H; Bui HX; del Rosario AD; Jennings TA; Rifkin MD; Fisher HA
    Cancer; 1994 Nov; 74(10):2811-8. PubMed ID: 7954242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.